United Kingdom· GB-APID-44941011000001103
Nemluvio 30mg powder and solvent for solution for injection pre-filled pens
A nemolizumab product containing nemolizumab, registered in United Kingdom by Galderma (UK) Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Nemolizumab is registered in 14 of 19 countries.
Countries holding a registration under ATC D11AH12 (nemolizumab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Nemolizumab · ATC D11AH12
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nemolizumab costs, country by country.
Normalised to the WHO defined daily dose (0.8 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nemolizumab · price per daily dose (0.8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$67.16
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Nemolizumab
- Manufacturer
- Galderma (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- D11AH12
- ATC class
- Nemolizumab
- Defined daily dose
- 0.8 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5020465204008
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nemolizumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandNemluvioGalderma International
- BelgiumNemluvio 30 mgGalderma International
- PolandNemluvioGalderma International
- SwedenNemluvio 30 mg Pulver och vätska till injektionsvätska, lösning i förfylld injektionspennaGalderma International
- SwitzerlandNemluvio 30 mg, Pulver und Lösungsmittel für Injektionslösung im FertigpenGalderma SA
- SpainNEMLUVIO 30 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN PLUMA PRECARGADAGalderma International
- NorwayNemluvioGalderma International
- CzechiaNEMLUVIOGalderma International, La Défense
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nemluvio
- Liechtenstein · Nemluvio
- Norway · Nemluvio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/562f8459-8026-49a0-8099-2b34678f99b7 GET /v1/drugs/562f8459-8026-49a0-8099-2b34678f99b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44941011000001103",
"desc": "Nemluvio 30mg powder and solvent for solution for injection pre-filled pens (Galderma (UK) Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "45160811000001101",
"source": "dmd",
"vtm_id": "45154811000001104",
"strength": "30 mg",
"substance": "Nemolizumab",
"ingredient": "Nemolizumab",
"supplier_code": "138401000001109"
}See everything about nemolizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.